PE Ratio
N/A
Fri, 29 Nov 2024 21:58:05 GMT
Summary:
CRISPR Therapeutics AG price to earnings ratio is not available.CRSP PE Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CRSP PE Ratio Performance
PeriodPeriod | PE ratioPE ratio | PricePrice | TTM EPSTTM EPS | TTM revenueTTM revenue |
---|---|---|---|---|
todaytoday | - | -0.4% | +12.5% | - |
1 m1 month | - | +4.3% | - | - |
3 m3 months | - | +5.6% | - | - |
6 m6 months | - | -4.3% | - | - |
ytdytd | - | -19.1% | - | - |
1 y1 year | - | -26.6% | +37.4% | - |
5 y5 years | - | -29.1% | -508.7% | - |
CRSP PE Ratio High & Low
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1 month | ||||
3 m | 3 months | ||||
6 m | 6 months | ||||
1 y | 1 year | ||||
3 y | 3 years | 20.45 | 11.98 | ||
5 y | 5 years | 218.78 | 11.98 | ||
alltime | all time | 218.78 | 11.98 |
CRISPR Therapeutics AG PE Ratio History
Date | Value |
---|---|
2021 | 17.14(-72.7%) |
Date | Value |
---|---|
2019 | 62.79 |
FAQ
- What is the all time high PE ratio for CRISPR Therapeutics AG?
What is the all time high PE ratio for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high price to earnings ratio is 218.78